Shareholders approve sale of Madison's TomoTherapy
TomoTherapy Inc.’s stockholders have approved the company’s sale to Accuray Inc., and the acquisition is expected to close within one to two business days, Accuray announced Thursday. Stockholder’s owning 79% of TomoTherapy’s outstanding shares voted in favor of the sale to Accuray. (MILWAUKEE JOURNAL SENTINEL, 6/10)
To access this post, you must purchase Premium Subscription - Daily Email and Full Website Access.